Moneycontrol reported in August that some drug makers are working towards producing APIs and key starting materials in house, while others have started qualifying Indian sources for procurement.from Moneycontrol Business News https://ift.tt/2Swu9aP
Tuesday, October 30, 2018
Indian API makers expect rise in order inflows amid price hikes, supply disruption in China
Moneycontrol reported in August that some drug makers are working towards producing APIs and key starting materials in house, while others have started qualifying Indian sources for procurement.from Moneycontrol Business News https://ift.tt/2Swu9aP
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment